SCHEMBL12226742

SCHEMBL12226742

CC(=O)OC(C)(C)C(=O)C/C=C(/C)CCC/C(C)=C/COc1ccc2ccc(=O)oc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.68
CA1 P00915 1/20 0.68
CA7 P43166 1/20 0.68
CA9 Q16790 1/20 0.68
CA13 Q8N1Q1 1/20 0.68
NDUFS8 O00217 7/20 0.61
COXFA4 O00483 7/20 0.61
NDUFAB1 O14561 7/20 0.61
NDUFA1 O15239 7/20 0.61
NDUFS4 O43181 7/20 0.61
NDUFB5 O43674 7/20 0.61
NDUFB3 O43676 7/20 0.61
NDUFC1 O43677 7/20 0.61
NDUFA2 O43678 7/20 0.61
NDUFS5 O43920 7/20 0.61
NDUFS7 O75251 7/20 0.61
NDUFS2 O75306 7/20 0.61
NDUFS6 O75380 7/20 0.61
NDUFB1 O75438 7/20 0.61
NDUFS3 O75489 7/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14351066 0.81 CA12 (1.00) CA12CA1CA7CA9CA13
Auraptene SCHEMBL2535034 0.76 ALOX15 (1.00) CA12CA1CA7CA9CA13
SCHEMBL29999425 0.76 NDUFS8 (0.83) CA12CA1CA7CA9CA13
Auraptene SCHEMBL2535029 0.76 ALOX15 (1.00) CA12CA1CA7CA9CA13
SCHEMBL18265492 0.76 KDM4E (0.78) CA12CA1CA7CA9CA13
SCHEMBL24700226 0.75 NDUFS8 (0.81) CA12CA1CA7CA9CA13
Umbelliprenin SCHEMBL28133292 0.75 ALOX15 (1.00) CA12CA1CA7CA9CA13
Umbelliprenin SCHEMBL18265478 0.75 ALOX15 (1.00) CA12CA1CA7CA9CA13
Umbelliprenin SCHEMBL26641528 0.75 ALOX15 (1.00) CA12CA1CA7CA9CA13
R-(+)-Marmin SCHEMBL29353819 0.75 NDUFS8 (0.83) CA12CA1CA7CA9CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044094-B2 Agents for preventing and treating disorders connected to impaired neurotransmission DSM IP ASSETS B.V. (NL) 2011-10-25 US disclosed
US-8044094-B2 Agents for preventing and treating disorders connected to impaired neurotransmission DSM IP ASSETS B.V. (NL) 2011-10-25 US disclosed
EP-1802298-B1 NOVEL AGENTS FOR PREVENTING AND TREATING DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION DSM IP ASSETS BV (NL) 2008-12-31 EP disclosed